Galectins as Regulators of Tumor Growth and Invasion by Targeting Distinct Cell Surface Glycans and Implications for Drug Design

Galectins

Volumn , Issue , 2008, Pages 71-85

  Gabius, Hans Joachim ^a   Wu, Albert M ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Compound libraries and dendrimers; Drug design galectin growth invasion regulatory activity; Galectins tumor growth regulators

Indexed keywords

EID: 84887258429     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470378076.ch4     Document Type: Chapter

References (44)

1. Gabius H-J. Biological information transfer beyond the genetic code: the sugar code. Naturwissenschaften 2000;87:108-121.
2. Gabius H-J, Siebert H-C, André S, Jiménez-Barbero J, R€udiger H. Chemical biology of the sugar code. ChemBioChem 2004;5:740-764.
3. Gabius H-J. Endogenous lectins in tumors and the immune system. Cancer Invest 1987;5:39-46.
4. Gabius H-J. Animal lectins. Eur J Biochem 1997;243:543-576.
5. Gabius H-J. Cell surface glycans: the why and how of their functionality as biochemical signals in lectin-mediated information transfer. Crit Rev Immunol 2006;26:43-80.
6. Villalobo A, Nogales-Gonzalés A, Gabius H-J. A guide to signaling pathways connecting protein-glycan interaction with the emerging versatile effector functionality of mammalian lectins. Trends Glycosci Glycotechnol 2006;18:1-37.
7. Gabius H-J, Darro F, Remmelink M, André S, Kopitz J, Danguy A, Gabius S, Salmon I, Kiss R. Evidence for stimulation of tumor proliferation in cell lines and histotypic cultures by clinically relevant low doses of the galactoside-binding mistletoe lectin, a component of proprietary extracts. Cancer Invest 2001;19:114-126.
8. André S, Kojima S, Yamazaki N, Fink C, Kaltner H, Kayser K, Gabius H-J. Galectins-1 and -3 and their ligands in tumor biology. J Cancer Res Clin Oncol 1999;125:461-474.
9. Leffler H, Barondes SH. Specificity of binding of soluble rat lung lectins to substituted and unsubstituted mammalian b-galactosides. J Biol Chem 1986;261:10119-10126.
10. Gabius H-J. Influence of type of linkage and spacer on the interaction of b-galactosidebinding proteins with immobilized affinity ligands. Anal Biochem 1990;189:91-94.
11. Ahmad N, Gabius H-J, Kaltner H, André S, Kuwabara I, Liu F-T, Oscarson S, Norberg T, Brewer CF. Thermodynamic binding studies of cell surface carbohydrate epitopes to galectins-1, -3 and -7. Evidence for differential binding specificities. Can J Chem 2002;80:1096-1104.
12. Wu AM, Singh T, Liu J-H, Krzeminski M, Russwurm R, Siebert H-C, Bonvin AMJJ, André S, Gabius H-J. Activity-structure correlations in divergent lectin evolution: fine specificity of chicken galectin CG-14 and computational analysis of flexible ligand docking for CG-14 and the closely related CG-16. Glycobiology 2007;17:165-184.
13. He L, André S, Siebert H-C, Helmholz H, Niemeyer B, Gabius H-J. Detection of ligandand solvent-induced shape alterations of cell-growth-regulatory human lectin galectin-1 in solution by small angle neutron and X-ray scattering. Biophys J 2003;85:511-524.
14. López-Lucendo MF, Solís D, André S, Hirabayashi J, Kasai K-i, Kaltner H, Gabius H-J, Romero A. Growth-regulatory human galectin-1: crystallographic characterisation of the structural changes induced by single-site mutations and their impact on the thermodynamics of ligand binding. J Mol Biol 2004;343:957-970.
15. Wu AM,Wu JH, Tsai M-S, Kaltner H, Gabius H-J. Carbohydrate specificity of a galectin from chicken liver (CG-16). Biochem J 2001;358:529-538.
16. Wu AM, Wu JH, Tsai M-S, Liu J-H, André S, Wasano K, Kaltner H, Gabius H-J. Fine specificity of domain-I of recombinant tandem-repeat-type galectin-4 from rat gastrointestinal tract (G4-N). Biochem J 2002;367:653-664.
17. Wu AM, Wu JH, Liu J-H, Singh T, André S, Kaltner H, Gabius H-J. Effects of polyvalency of glycotopes and natural modifications of human blood group ABH/Lewis sugars at the Galb1-terminated core saccharides on the binding of domain-I of recombinant tandem-repeat-type galectin-4 from rat gastrointestinal tract (G4-N) Biochimie 2004;86:317-326.
18. Wu AM, Singh T,Wu JH, Lensch M, André S, Gabius H-J. Interaction profile of galectin-5 with free saccharides and mammalian glycoproteins: probing its fine-specificity and the effect of naturally clustered ligand presentation. Glycobiology 2006;16:524-537.
19. André S, Unverzagt C, Kojima S, Frank M, Seifert J, Fink C, Kayser K, von der Lieth C-W, Gabius H-J. Determination of modulation of ligand properties of synthetic complex-type biantennary N-glycans by introduction of bisecting GlcNAc in silico, in vitro and in vivo. Eur J Biochem 2004;271:118-134.
20. André S, Kojima S, Prahl I, Lensch M, Unverzagt C, Gabius H-J. Introduction of extended LEC14-type branching into core-fucosylated biantennary N-glycan. Glycoengineering for enhanced cell binding and serum clearance of the neoglycoprotein. FEBS J 2005; 272:1986-1998.
21. André S, Kozár T, Schuberth R, Unverzagt C, Kojima S, Gabius H-J. Substitutions in the N-glycan core as regulators of biorecognition: the case of core-fucose and bisecting GlcNAc moieties. Biochemistry 2007;46:6984-6995.
22. Dam TK, Gabius H-J, André S, Kaltner H, Lensch M, Brewer CF. Galectins bind to the multivalent glycoprotein asialofetuin with enhanced affinities and a gradient of decreasing binding constants. Biochemistry 2005;44:12564-12571.
23. Fischer C, Sanchez-Ruderisch H,Welzel M,Wiedenmann B, Sakai T, André S, Gabius HJ, Khachigian L, Detjen K, Rosewicz S. Galectin-1 interacts with the a5b1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27. J Biol Chem 2005;280:37266-37277.
24. André S, Sanchez-Ruderisch H, Nakagawa H, Buchholz M, Kopitz J, Forberich P, Kemmner W, Böck C, Deguchi K, Detjen KM, Wiedenmann B, von Knebel Döberitz M, Gress TM, Nishimura S-I, Rosewicz S, Gabius H-J. Tumor suppressor p16INK4a: modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells. FEBS J 2007;274:3233-3256.
25. Sturm A, Lensch M, André S, Kaltner H, Wiedenmann B, Rosewicz S, Dignass AU, Gabius H-J. Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation. J Immunol 2004;173:3825-3837.
26. Pace KE, Hahn HP, Pang M, Nguyen JT, Baum LG. CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death. J Immunol 2000;165:2331-2334.
27. Rappl G, Abken H, Muche JM, Sterry W, Tilgen W, André S, Kaltner H, Ugurel S, Gabius H-J, Reinhold U. CD4{thorn}CD7-leukemic T cells from patients with Sézary syndrome are protected from galectin-1-triggered T cell death. Leukemia 2002;16:840-845.
28. Kopitz J, von Reitzenstein C, Burchert M, Cantz M, Gabius H-J. Galectin-1 is a major receptor for gangliosideGM1, a product of the growth-controlling activity of a cell surface ganglioside sialidase, on human neuroblastoma cells in culture. J Biol Chem 1998;273:11205-11211.
29. Kopitz J, von Reitzenstein C, André S, Kaltner H, Uhl J, Ehemann V, Cantz M, Gabius H-J. Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3. J Biol Chem 2001;276:35917-35923.
30. André S, Kaltner H, Lensch M, Russwurm R, Siebert H-C, Fallsehr C, Tajkhorshid E, Heck AJR, von Knebel-Döberitz M, Gabius H-J, Kopitz J. Determination of structural and functional overlap/divergence of five prototype galectins by analysis of the growthregulatory interaction with gangliosideGM1in silico and in vitro on human neuroblastoma cells. Int J Cancer 2005;114:46-57.
31. Siebert H-C,André S, Lu S-Y, Frank M, Kaltner H, vanKuik JA,Korchagina EY, Bovin NV, Tajkhorshid E,Kaptein R, Vliegenthart JFG, von der Lieth C-W, Jiménez-Barbero J,Kopitz J, Gabius H-J. Unique conformer selection of human growth-regulatory lectin galectin-1 for ganglioside GM1 versus bacterial toxins. Biochemistry 2003;42:14762-14773.
32. Siebert H-C, Gilleron M, Kaltner H, von der Lieth C-W, Kozár T, Bovin NV, Korchagina EY, Vliegenthart JFG, Gabius H-J. NMR-based, molecular dynamics- and random walk molecular mechanics-supported study of conformational aspects of a carbohydrate ligand (Galb1-2Galb1-R) for an animal galectin in the free and in the bound state. Biochem Biophys Res Commun 1996;219:205-212.
33. Asensio JL, Espinosa JF, Dietrich H, Cañada FJ, Schmidt RR, Martín-Lomas M, André S, Gabius H-J, Jiménez-Barbero J. Bovine heart galectin-1 selects a distinct (syn) conformation of C-lactose, a flexible lactose analogue. J Am Chem Soc 1999;121: 8995-9000.
34. Siebert H-C, Born K, André S, Frank M, Kaltner H, von der Lieth C-W, Heck AJR, Jiménez-Barbero J, Kopitz J, Gabius H-J. Carbohydrate chain of ganglioside GM1 as a ligand: identification of the binding strategies of three 15mer peptides and their divergence from the binding modes of growth-regulatory galectin-1 and cholera toxin. Chem Eur J 2006;12:388-402.
35. Rorive S, Belot N, Decaestecker C, Lefranc F, Gordower L, Micik S, Maurage C-A, Kaltner H, Ruchoux M-M, Danguy A, Gabius H-J, Salmon I, Kiss R, Camby I. Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma. Glia 2001;33:241-255.
36. Camby I, Belot N, Lefranc F, Sadeghi N, de Launoit Y, Kaltner H, Musette S, Darro F, Danguy A, Salmon I, Gabius H-J, Kiss R. Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases. J Neuropathol Exp Neurol 2002;61:585-596.
37. André S, Pei Z, Siebert H-C, Ramstrm O, Gabius H-J. Glycosyldisulfides from dynamic combinatorial libraries as O-glycoside mimetics for plant and mammalian lectins: their reactivities in solid-phase and cell assays and conformational analysis by molecular dynamics simulations. Bioorg Med Chem 2006;14:6314-6323.
38. André S, Maljaars CEP, Halkes KM, Gabius H-J, Kamerling JP. Discovery of galectin ligands in fully randomized combinatorial one-bead-one-compound (glyco)peptide libraries. Bioorg Med Chem Lett 2007;17:793-798.
39. Rotblat B, Niv H, André S, Kaltner H, Gabius H-J, Kloog Y. Galectin-1(L11A) predicted from a computed galectin-1 farnesyl-binding pocket selectively inhibits Ras-GTP. Cancer Res 2004;64:3112-3118.
40. André S, Cejas Ortega PJ, Alamino Perez M, Roy R, Gabius H-J. Lactose-containing starburst dendrimers: influence of dendrimer generation and binding-site orientation of receptors (plant/animal lectins and immunoglobulins) on binding properties. Glycobiology 1999;9:1253-1261.
41. André S, Pieters RJ, Vrasidas I, Kaltner H, Kuwabara I, Liu F-T, Liskamp RMJ, Gabius H-J. Wedgelike glycodendrimers as inhibitors of binding ofmammalian galectins to various glycoproteins, lactose maxiclusters and cell surface glycoconjugates. Chem Bio Chem 2001;2:822-830.
42. André S, Kaltner H, Furuike T, Nishimura S-I, Gabius H-J. Persubstituted cyclodextrinbased glycoclusters as inhibitors of protein-carbohydrate recognition using purified plant and mammalian lectins and wild-type and lectin-gene-transfected tumor cells as targets. Bioconjug Chem 2004;15:87-98.
43. André S, Liu B, Gabius H-J, Roy R. First demonstration of differential inhibition of lectin binding by synthetic tri- and tetravalent glycoclusters from cross-coupling of rigidified 2-propynyl lactoside. Org Biomol Chem 2003;1:3909-3916.
44. Ahmad N, Gabius H-J, André S, Kaltner H, Sabesan S, Roy R, Liu B, Macaluso F, Brewer CF. Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes. J Biol Chem 2004;279:10841-10847.